USPTO serial 86563427
STRATEGIA THERAPEUTICS
Reviewed by CopyMark Law Group
Reg. 4974454Status 710
- Filing date
- Status date
- Registration date
- Jun 7, 2016
- Examiner
- REEVES, APRIL ELIZABETH
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with STRATEGIA THERAPEUTICS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
BOSTON, MA
Boston, MA
Boston, MA
NATICK, MA
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Matthew D. Asbell
MATTHEW D. ASBELL Ladas & Parry Llp1040 Avenue Of The AmericasNew York, NY 10018-3703UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 035 | Business development services for global pharmaceutical companies | SECTION 8 - CANCELLED | Apr 8, 2015 |
| 040 | Manufacturing services for others in the field of pharmaceutical preparations and medicines | SECTION 8 - CANCELLED | Apr 8, 2015 |
| 042 | Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Pharmaceutical drug development services in the field of oncology drugs; Conducting clinical trials for others in the field of oncology; Laboratory research services relating to pharmaceutical preparations and medicines; Conducting research and clinical trials for others relating to medical devices and pharmaceuticals in the field of ophthalmology | SECTION 8 - CANCELLED | Apr 8, 2015 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by STRATEGIA THERAPEUTICS, INC.
- Other trademarks owned by Boston Strategics Corp.
- Other trademarks owned by Boston Strategics Corp.
- Other trademarks owned by STRATEGIA THERAPEUTICS, INC.
- Other trademarks in Class 035
- Other trademarks in Class 040
- Other trademarks in Class 042
- Similar marks named STRATEGIA THERAPEUTICS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 23, 2022 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Jun 7, 2021 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Aug 24, 2017 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Aug 24, 2017 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Jun 7, 2016 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| May 3, 2016 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| May 2, 2016 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Apr 20, 2016 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Mar 30, 2016 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Mar 24, 2016 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Feb 19, 2016 | IUAF | USE AMENDMENT FILED | — |
| Feb 19, 2016 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Oct 6, 2015 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Aug 11, 2015 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 11, 2015 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 22, 2015 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 9, 2015 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jul 9, 2015 | ALIE | ASSIGNED TO LIE | — |
| Jun 24, 2015 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 24, 2015 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jun 24, 2015 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jun 24, 2015 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jun 24, 2015 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jun 17, 2015 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 24, 2015 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 17, 2015 | NWAP | NEW APPLICATION ENTERED | — |